Which neurological diseases benefit from neuroprotective agents?
Neuroprotective agents are beneficial in a range of neurological conditions, including:
- Stroke: Agents like Nimodipine and Edaravone are used to reduce neuronal damage following ischemic strokes. - Parkinson's Disease: Selegiline and Rasagiline have been shown to have neuroprotective properties by inhibiting monoamine oxidase-B (MAO-B). - Alzheimer's Disease: Memantine acts as an NMDA receptor antagonist and helps in reducing excitotoxic damage. - Amyotrophic Lateral Sclerosis (ALS): Riluzole has been approved for its neuroprotective effects in ALS patients. - Multiple Sclerosis (MS): Fingolimod and Dimethyl Fumarate are examples of agents with neuroprotective properties used in MS management.
